COVID-19 infections impact cardiovascular disease

The full impact of COVID-19 infections, even mild and moderate cases, is still being understood. And now, recent research has revealed that the medium and long-term impact of an acute illness may be associated with cardiovascular events, such as venous thromboembolism, stroke and myocardial infarction.

U.K.-based researchers examined more than 20,000 participants from the UK Biobank who had recorded COVID-19 infection status. The UK Biobank is a large cohort of middle-aged volunteers recruited between 2006 and 2010. Researchers published their findings in Heart.

The analysis found that of the patients with confirmed COVID-19, 80% did not require hospitalization. In 9% of cases, compared to 0.7% of control subjects, evidence of at least one incident of myocardial infarction, stroke, heart failure, atrial fibrillation, venous thromboembolism, pericarditis, cardiovascular mortality, ischaemic heart disease mortality and all-cause mortality was recorded. Cardiovascular events were 3% more frequent in those with compared to those without (0.5%) confirmed COVID-19 infection.

“In those hospitalized with COVID-19 as a primary illness, the risk of venous thromboembolism, heart failure, stroke and myocardial infarction were markedly elevated,” wrote first author Anda Bularga, of the Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, U.K., et al.

In addition, there was a vast excess of mortality in all groups with COVID-19, and it was the greatest among those hospitalized with COVID-19 as a primary or secondary diagnosis compared to those who were not admitted. Researchers also found that cardiovascular risks were greatest in the first 30 days after infection, but remained higher than controls after that initial 30-day period. 

The study adds to the ongoing dialogue about the long-term impact of a COVID-19 infection. The findings underscore the potential need for greater attention to management of cardiovascular risk and a low threshold for cardiovascular investigations of patients exposed to COVID-19 for prevention and timely treatment of cardiovascular events.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”